Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Recovery Management Checkups for Primary Care (RMC-PC): Replication and Sustainability within FQHC Practice

Award Number: R01AA024440
ORGANIZATION: NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/03/2026
PERIOD OF PERFORMANCE END DATE: 08/31/2031

Group Awards By:

View Award Description

Recovery Management Checkups for Primary Care (RMC-PC): Replication and Sustainability within FQHC Practice - Abstract Alcohol and other substance use disorders (A/SUD) remain a major public health crisis in the United States, contributing to more than 220,000 deaths between October 2023 and September 2024 and accounting for 6.7% of all deaths nationally. A/SUDs are the second leading cause of death among individuals under 30 and the tenth overall, with harms extending far beyond overdose to include various chronic illnesses (e.g., cardiovascular disease, liver disease, and multiple cancers). Evidence-based A/SUD treatments can reduce substance use and prevent poisoning, overdose, and other chronic health impacts; however, fewer than one in four individuals in need receive care, and many who do fail to remain engaged for the three months demonstrated to be associated with sustained recovery. Recovery Management Checkups for Primary Care (RMC-PC) provides a motivational, chronic-care approach to improve treatment linkage, engagement, and re- engagement following relapse while addressing structural and motivational barriers. Over two decades of research and six randomized trials demonstrate RMC’s effectiveness in increasing treatment participation, reducing substance use, and improving abstinence, yet the model has not been implemented in real-world primary care, limiting its public health reach. This study will integrate RMC-PC into Federally Qualified Health Centers (FQHCs) and assess whether FQHC staff can deliver the model with outcomes equivalent to those achieved by research staff. The hybrid type 2 effectiveness-implementation design is guided by the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework. Specific Aim 1 involves collaboration with a primary care Stakeholder Board to improve acceptability, appropriateness, and feasibility through exploration phase intervention adaptation and sustainment pathway identification. Specific Aim 2 will conduct a pragmatic trial (N=432) to test the equivalence of patient outcomes between FQHC and research staff, with the primary hypothesis that both groups will show similar improvements in days of A/SUD treatment over 12 months. Additional analyses will assess behavioral and physical health outcomes. Specific Aim 3 employs a mixed-method case study approach to evaluate the impact of an 18-month multi-component, implementation strategy on fidelity and sustainability, using administrator, staff, and patient-level data. Mixed- method integration will provide insights into how implementation strategies drive outcomes, while case comparisons will enhance the theoretical generalizability of findings. RMC-PC’s potential for sustainment at study sites will be enhanced by Stakeholder Board collaboration to identify pathways for long-term financial stability and site-level, facilitation-guided sustainment planning. This study will advance the scalability of RMC- PC as an effective chronic-disease-focused intervention to improve A/SUD treatment linkage and sustained recovery, with results informing future implementation research.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $597,599 )
2026	2026	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	6	9/7/2026	COMPETING CONTINUATION	$597,599
														Subtotal = $597,599

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2022	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	5	4/28/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	5	1/23/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2022	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	5	11/30/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $353,928 )
2022	2022	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	001	5	6/20/2022	NON-COMPETING CONTINUATION	$35,393
2022	2022	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	5	12/29/2021	NON-COMPETING CONTINUATION	$318,535
														Subtotal = $353,928

Issue Date FY: 2021 ( Subtotal = $572,747 )
2021	2021	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	4	3/2/2021	NON-COMPETING CONTINUATION	$572,747
														Subtotal = $572,747

Issue Date FY: 2020 ( Subtotal = $576,464 )
2020	2020	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	3	12/24/2019	NON-COMPETING CONTINUATION	$518,817
2020	2020	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	001	3	4/2/2020	NON-COMPETING CONTINUATION	$57,647
														Subtotal = $576,464

Issue Date FY: 2019 ( Subtotal = $579,301 )
2019	2019	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	2	12/24/2018	NON-COMPETING CONTINUATION	$579,301
														Subtotal = $579,301

Issue Date FY: 2017 ( Subtotal = $538,957 )
2017	2017	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	1	1/27/2017	NEW	$538,957
														Subtotal = $538,957

Grand Total All Awards = $3,218,996

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Recovery Management Checkups for Primary Care (RMC-PC): Replication and Sustainability within FQHC Practice

Award Number: R01AA024440

ORGANIZATION: NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/03/2026

PERIOD OF PERFORMANCE END DATE: 08/31/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer